Tapewire

NYSE · USD

SHW

SHERWIN WILLIAMS CO

Export transactions ↓
Tapewire entity
2948
SEC CIK
0000089800
Parsed reports
715

Last 12 months

Inside the activity.

0 purchase rows · 4 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202602
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202602
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
October 20, 2020 Filed Oct 22, 2020 17:13 UTC
GILLIGAN THOMAS PSVP-Human Resources
GrantEmployee Stock Option (Right to Buy) · Derivative 2,800 $0.00 Strike: $681.13 $0.00
Disclosure

SEC source: 0001209191-20-055541 · doc4.xml · derivative · entry 1

GILLIGAN THOMAS P · CIK 0001661198 · SVP-Human Resources

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,800

Underlying: Common Stock · 2,800 shares

Expires 2030-10-19

F1 · derivative.exercise_date: The option vests in three annual installments of 934, 933 and 933 beginning on October 20, 2021.

Read SEC document
October 20, 2020 Filed Oct 22, 2020 17:26 UTC
IPPOLITO PETER J.President, The Americas Group
GrantEmployee Stock Option (Right to Buy) · Derivative 5,000 $0.00 Strike: $681.13 $0.00
Disclosure

SEC source: 0001209191-20-055542 · doc4.xml · derivative · entry 1

IPPOLITO PETER J. · CIK 0001729232 · President, The Americas Group

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,000

Underlying: Common Stock · 5,000 shares

Expires 2030-10-19

F1 · derivative.exercise_date: The option vests in three annual installments of 1,667, 1,667 and 1,666 beginning on October 20, 2021.

Read SEC document
October 20, 2020 Filed Oct 22, 2020 17:07 UTC
ERTER AARON MPresident, Perf Coatings Grp
GrantEmployee Stock Option (Right to Buy) · Derivative 4,300 $0.00 Strike: $681.13 $0.00
Disclosure

SEC source: 0001209191-20-055539 · doc4.xml · derivative · entry 1

ERTER AARON M · CIK 0001713958 · President, Perf Coatings Grp

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,300

Underlying: Common Stock · 4,300 shares

Expires 2030-10-19

F1 · derivative.exercise_date: The option vests in three annual installments of 1,434, 1,433 and 1,433 beginning on October 20, 2021.

Read SEC document
October 20, 2020 Filed Oct 22, 2020 17:03 UTC
Baxter Joel D.Pres. & GM, Glob. Supply Chain
GrantEmployee Stock Option (Right to Buy) · Derivative 3,200 $0.00 Strike: $681.13 $0.00
Disclosure

SEC source: 0001209191-20-055535 · doc4.xml · derivative · entry 1

Baxter Joel D. · CIK 0001666161 · Pres. & GM, Glob. Supply Chain

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,200

Underlying: Common Stock · 3,200 shares

Expires 2030-10-19

F1 · derivative.exercise_date: The option vests in three annual installments of 1,067, 1,067 and 1,066 beginning on October 20, 2021.

Read SEC document
October 02, 2020 Filed Oct 6, 2020 18:11 UTC GrantPhantom Stock Units · Derivative 53.71 $688.84 $36,997.60
Disclosure

SEC source: 0001209191-20-053982 · doc4.xml · derivative · entry 1

KROPF SUSAN J · CIK 0001051402 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,232.45

Underlying: Common Stock · 53.71 shares

Expires not disclosed

F1 · derivative.exercise_price: Represents the number of phantom stock units acquired by the reporting person (in an exempt transaction) under the 2005 Director Deferred Fee Plan. Each phantom stock unit is the economic equivalent of one share of common stock. The phantom stock units become payable solely in cash generally upon the reporting person's retirement.

F1 · shares: Represents the number of phantom stock units acquired by the reporting person (in an exempt transaction) under the 2005 Director Deferred Fee Plan. Each phantom stock unit is the economic equivalent of one share of common stock. The phantom stock units become payable solely in cash generally upon the reporting person's retirement.

F1 · derivative.exercise_date: Represents the number of phantom stock units acquired by the reporting person (in an exempt transaction) under the 2005 Director Deferred Fee Plan. Each phantom stock unit is the economic equivalent of one share of common stock. The phantom stock units become payable solely in cash generally upon the reporting person's retirement.

F1 · derivative.expiration_date: Represents the number of phantom stock units acquired by the reporting person (in an exempt transaction) under the 2005 Director Deferred Fee Plan. Each phantom stock unit is the economic equivalent of one share of common stock. The phantom stock units become payable solely in cash generally upon the reporting person's retirement.

F2 · balance_after: Includes phantom stock units acquired pursuant to the dividend reinvestment feature of the plan.

Read SEC document
October 02, 2020 Filed Oct 6, 2020 18:09 UTC GrantCommon Stock 58.07 $688.84 $40,000.94
Disclosure

SEC source: 0001209191-20-053981 · doc4.xml · nonDerivative · entry 1

WUNNING STEVEN H · CIK 0001171788 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Deferred Plan

Disclosed balance after: 2,037.99

F1 · kind: Represents the number of phantom stock units acquired by the reporting person (in an exempt transaction) under the 2005 Director Deferred Fee Plan. Each phantom stock unit is the economic equivalent of one share of common stock. The phantom stock units become payable solely in stock generally upon the reporting person's retirement.

F2 · balance_after: Phantom stock units listed are held pursuant to the 2005 Director Deferred Fee Plan, which includes phantom stock units acquired pursuant to the dividend reinvestment feature of such plan.

Read SEC document
October 02, 2020 Filed Oct 6, 2020 18:07 UTC GrantCommon Stock 45.37 $688.84 $31,252.67
Disclosure

SEC source: 0001209191-20-053979 · doc4.xml · nonDerivative · entry 1

THAMAN MICHAEL H · CIK 0001228309 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Deferred Plan

Disclosed balance after: 950.04

F1 · kind: Represents the number of phantom stock units acquired by the reporting person (in an exempt transaction) under the 2005 Director Deferred Fee Plan. Each phantom stock unit is the economic equivalent of one share of common stock. The phantom stock units become payable solely in stock generally upon the reporting person's retirement.

F2 · balance_after: Phantom stock units listed are held pursuant to the 2005 Director Deferred Fee Plan, which includes phantom stock units acquired pursuant to the dividend reinvestment feature of such plan.

Read SEC document
October 02, 2020 Filed Oct 6, 2020 18:05 UTC GrantCommon Stock 11.34 $688.84 $7,811.45
Disclosure

SEC source: 0001209191-20-053978 · doc4.xml · nonDerivative · entry 1

POON CHRISTINE A · CIK 0001189014 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Deferred Plan

Disclosed balance after: 656.02

F1 · kind: Represents the number of phantom stock units acquired by the reporting person (in an exempt transaction) under the 2005 Director Deferred Fee Plan. Each phantom stock unit is the economic equivalent of one share of common stock. The phantom stock units become payable solely in stock generally upon the reporting person's retirement.

F2 · balance_after: Phantom stock units listed are held pursuant to the 2005 Director Deferred Fee Plan, which includes phantom stock units acquired pursuant to the dividend reinvestment feature of such plan.

Read SEC document
October 02, 2020 Filed Oct 6, 2020 18:03 UTC GrantCommon Stock 52.63 $688.84 $36,253.65
Disclosure

SEC source: 0001209191-20-053977 · doc4.xml · nonDerivative · entry 1

KRAMER RICHARD J · CIK 0001201067 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Deferred Plan

Disclosed balance after: 3,146.32

F1 · kind: Represents the number of phantom stock units acquired by the reporting person (in an exempt transaction) under the 2005 Director Deferred Fee Plan. Each phantom stock unit is the economic equivalent of one share of common stock. The phantom stock units become payable solely in stock generally upon the reporting person's retirement.

F2 · balance_after: Phantom stock units listed are held pursuant to the 2005 Director Deferred Fee Plan, which includes phantom stock units acquired pursuant to the dividend reinvestment feature of such plan.

Read SEC document
October 02, 2020 Filed Oct 6, 2020 17:59 UTC GrantCommon Stock 11.34 $688.84 $7,811.45
Disclosure

SEC source: 0001209191-20-053976 · doc4.xml · nonDerivative · entry 1

ANDERSON KERRII B · CIK 0001227159 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Deferred Plan

Disclosed balance after: 88.17

F1 · kind: Represents the number of phantom stock units acquired by the reporting person (in an exempt transaction) under the 2005 Director Deferred Fee Plan. Each phantom stock unit is the economic equivalent of one share of common stock. The phantom stock units become payable solely in stock generally upon the reporting person's retirement.

F2 · balance_after: Phantom stock units listed are held pursuant to the 2005 Director Deferred Fee Plan, which includes phantom stock units acquired pursuant to the dividend reinvestment feature of such plan.

Read SEC document
September 28, 2020 Filed Sep 30, 2020 18:36 UTC
MORIKIS JOHN GDirector · Chairman and CEO
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 12,614 $0.00 Strike: $270.12 $0.00
Disclosure

SEC source: 0001209191-20-052428 · doc4.xml · derivative · entry 14

MORIKIS JOHN G · CIK 0001203523 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,019

Underlying: Common Stock · 12,614 shares

Expires 2026-10-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 28, 2020 Filed Sep 30, 2020 18:36 UTC
MORIKIS JOHN GDirector · Chairman and CEO
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 9,668 $0.00 Strike: $270.12 $0.00
Disclosure

SEC source: 0001209191-20-052428 · doc4.xml · derivative · entry 13

MORIKIS JOHN G · CIK 0001203523 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 9,668 shares

Expires 2026-10-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 28, 2020 Filed Sep 30, 2020 18:36 UTC
MORIKIS JOHN GDirector · Chairman and CEO
SaleCommon Stock 300 $711.66 $213,498.00
Disclosure

SEC source: 0001209191-20-052428 · doc4.xml · nonDerivative · entry 10

MORIKIS JOHN G · CIK 0001203523 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 103,024

F1 · kind: The exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 29, 2020.

F10 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $711.46 to $711.87 inclusive. The reporting person undertakes to provide to The Sherwin-Williams Company, any security holder of The Sherwin-Williams Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.

Read SEC document
September 28, 2020 Filed Sep 30, 2020 18:36 UTC
MORIKIS JOHN GDirector · Chairman and CEO
SaleCommon Stock 2,100 $710.71 $1,492,491.00
Disclosure

SEC source: 0001209191-20-052428 · doc4.xml · nonDerivative · entry 9

MORIKIS JOHN G · CIK 0001203523 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 103,324

F1 · kind: The exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 29, 2020.

F9 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $710.46 to $711.42 inclusive. The reporting person undertakes to provide to The Sherwin-Williams Company, any security holder of The Sherwin-Williams Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.

Read SEC document
September 28, 2020 Filed Sep 30, 2020 18:36 UTC
MORIKIS JOHN GDirector · Chairman and CEO
SaleCommon Stock 4,500 $709.83 $3,194,235.00
Disclosure

SEC source: 0001209191-20-052428 · doc4.xml · nonDerivative · entry 8

MORIKIS JOHN G · CIK 0001203523 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 105,424

F1 · kind: The exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 29, 2020.

F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $709.34 to $710.31 inclusive. The reporting person undertakes to provide to The Sherwin-Williams Company, any security holder of The Sherwin-Williams Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.

Read SEC document
September 28, 2020 Filed Sep 30, 2020 18:36 UTC
MORIKIS JOHN GDirector · Chairman and CEO
SaleCommon Stock 4,400 $708.70 $3,118,280.00
Disclosure

SEC source: 0001209191-20-052428 · doc4.xml · nonDerivative · entry 7

MORIKIS JOHN G · CIK 0001203523 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 109,924

F1 · kind: The exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 29, 2020.

F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $708.33 to $709.30 inclusive. The reporting person undertakes to provide to The Sherwin-Williams Company, any security holder of The Sherwin-Williams Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.

Read SEC document
September 28, 2020 Filed Sep 30, 2020 18:36 UTC
MORIKIS JOHN GDirector · Chairman and CEO
SaleCommon Stock 5,100 $707.88 $3,610,188.00
Disclosure

SEC source: 0001209191-20-052428 · doc4.xml · nonDerivative · entry 6

MORIKIS JOHN G · CIK 0001203523 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 114,324

F1 · kind: The exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 29, 2020.

F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $707.29 to $708.27 inclusive. The reporting person undertakes to provide to The Sherwin-Williams Company, any security holder of The Sherwin-Williams Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.

Read SEC document
September 28, 2020 Filed Sep 30, 2020 18:36 UTC
MORIKIS JOHN GDirector · Chairman and CEO
SaleCommon Stock 2,582 $706.75 $1,824,828.50
Disclosure

SEC source: 0001209191-20-052428 · doc4.xml · nonDerivative · entry 5

MORIKIS JOHN G · CIK 0001203523 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 119,424

F1 · kind: The exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 29, 2020.

F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $706.28 to $707.22 inclusive. The reporting person undertakes to provide to The Sherwin-Williams Company, any security holder of The Sherwin-Williams Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.

Read SEC document
September 28, 2020 Filed Sep 30, 2020 18:36 UTC
MORIKIS JOHN GDirector · Chairman and CEO
SaleCommon Stock 1,600 $705.64 $1,129,024.00
Disclosure

SEC source: 0001209191-20-052428 · doc4.xml · nonDerivative · entry 4

MORIKIS JOHN G · CIK 0001203523 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 122,006

F1 · kind: The exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 29, 2020.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $705.22 to $706.05 inclusive. The reporting person undertakes to provide to The Sherwin-Williams Company, any security holder of The Sherwin-Williams Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.

Read SEC document
September 28, 2020 Filed Sep 30, 2020 18:36 UTC
MORIKIS JOHN GDirector · Chairman and CEO
SaleCommon Stock 1,200 $704.53 $845,436.00
Disclosure

SEC source: 0001209191-20-052428 · doc4.xml · nonDerivative · entry 3

MORIKIS JOHN G · CIK 0001203523 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 123,606

F1 · kind: The exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 29, 2020.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $703.99 to $704.93 inclusive. The reporting person undertakes to provide to The Sherwin-Williams Company, any security holder of The Sherwin-Williams Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.

Read SEC document
September 28, 2020 Filed Sep 30, 2020 18:36 UTC
MORIKIS JOHN GDirector · Chairman and CEO
SaleCommon Stock 500 $703.29 $351,645.00
Disclosure

SEC source: 0001209191-20-052428 · doc4.xml · nonDerivative · entry 2

MORIKIS JOHN G · CIK 0001203523 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 124,806

F1 · kind: The exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 29, 2020.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $702.72 to $703.59 inclusive. The reporting person undertakes to provide to The Sherwin-Williams Company, any security holder of The Sherwin-Williams Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.

Read SEC document
September 28, 2020 Filed Sep 30, 2020 18:36 UTC
MORIKIS JOHN GDirector · Chairman and CEO
Exercise / conversionCommon Stock 22,282 $270.12 $6,018,813.84
Disclosure

SEC source: 0001209191-20-052428 · doc4.xml · nonDerivative · entry 1

MORIKIS JOHN G · CIK 0001203523 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 125,306

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 29, 2020.

Read SEC document
August 31, 2020 Filed Sep 2, 2020 20:58 UTC
MORIKIS JOHN GDirector · Chairman and CEO
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 7,966 $0.00 Strike: $270.12 $0.00
Disclosure

SEC source: 0001209191-20-049173 · doc4.xml · derivative · entry 12

MORIKIS JOHN G · CIK 0001203523 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,668

Underlying: Common Stock · 7,966 shares

Expires 2026-10-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 31, 2020 Filed Sep 2, 2020 20:58 UTC
MORIKIS JOHN GDirector · Chairman and CEO
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 14,316 $0.00 Strike: $239.55 $0.00
Disclosure

SEC source: 0001209191-20-049173 · doc4.xml · derivative · entry 11

MORIKIS JOHN G · CIK 0001203523 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 14,316 shares

Expires 2025-10-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 31, 2020 Filed Sep 2, 2020 20:58 UTC
MORIKIS JOHN GDirector · Chairman and CEO
SaleCommon Stock 100 $676.65 $67,665.00
Disclosure

SEC source: 0001209191-20-049173 · doc4.xml · nonDerivative · entry 8

MORIKIS JOHN G · CIK 0001203523 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 103,024

F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 29, 2020.

F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $676.61 to $676.66 inclusive. The reporting person undertakes to provide to The Sherwin-Williams Company, any security holder of The Sherwin-Williams Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.

Read SEC document
August 31, 2020 Filed Sep 2, 2020 20:58 UTC
MORIKIS JOHN GDirector · Chairman and CEO
SaleCommon Stock 100 $674.11 $67,411.00
Disclosure

SEC source: 0001209191-20-049173 · doc4.xml · nonDerivative · entry 7

MORIKIS JOHN G · CIK 0001203523 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 103,124

F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 29, 2020.

Read SEC document
August 31, 2020 Filed Sep 2, 2020 20:58 UTC
MORIKIS JOHN GDirector · Chairman and CEO
SaleCommon Stock 1,900 $673.28 $1,279,232.00
Disclosure

SEC source: 0001209191-20-049173 · doc4.xml · nonDerivative · entry 6

MORIKIS JOHN G · CIK 0001203523 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 103,224

F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 29, 2020.

F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $672.99 to $673.77 inclusive. The reporting person undertakes to provide to The Sherwin-Williams Company, any security holder of The Sherwin-Williams Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.

Read SEC document
August 31, 2020 Filed Sep 2, 2020 20:58 UTC
MORIKIS JOHN GDirector · Chairman and CEO
SaleCommon Stock 5,079 $672.42 $3,415,221.18
Disclosure

SEC source: 0001209191-20-049173 · doc4.xml · nonDerivative · entry 5

MORIKIS JOHN G · CIK 0001203523 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 105,124

F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 29, 2020.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $671.97 to $672.81 inclusive. The reporting person undertakes to provide to The Sherwin-Williams Company, any security holder of The Sherwin-Williams Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.

Read SEC document
August 31, 2020 Filed Sep 2, 2020 20:58 UTC
MORIKIS JOHN GDirector · Chairman and CEO
SaleCommon Stock 9,404 $671.38 $6,313,657.52
Disclosure

SEC source: 0001209191-20-049173 · doc4.xml · nonDerivative · entry 4

MORIKIS JOHN G · CIK 0001203523 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 110,203

F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 29, 2020.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $670.95 to $671.93 inclusive. The reporting person undertakes to provide to The Sherwin-Williams Company, any security holder of The Sherwin-Williams Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.

Read SEC document
August 31, 2020 Filed Sep 2, 2020 20:58 UTC
MORIKIS JOHN GDirector · Chairman and CEO
SaleCommon Stock 5,699 $670.48 $3,821,065.52
Disclosure

SEC source: 0001209191-20-049173 · doc4.xml · nonDerivative · entry 3

MORIKIS JOHN G · CIK 0001203523 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 119,607

F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 29, 2020.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $669.94 to $670.87 inclusive. The reporting person undertakes to provide to The Sherwin-Williams Company, any security holder of The Sherwin-Williams Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.

Read SEC document
August 31, 2020 Filed Sep 2, 2020 20:58 UTC
MORIKIS JOHN GDirector · Chairman and CEO
Exercise / conversionCommon Stock 7,966 $270.12 $2,151,775.92
Disclosure

SEC source: 0001209191-20-049173 · doc4.xml · nonDerivative · entry 2

MORIKIS JOHN G · CIK 0001203523 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 125,306

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 29, 2020.

Read SEC document
August 31, 2020 Filed Sep 2, 2020 20:58 UTC
MORIKIS JOHN GDirector · Chairman and CEO
Exercise / conversionCommon Stock 14,316 $239.55 $3,429,397.80
Disclosure

SEC source: 0001209191-20-049173 · doc4.xml · nonDerivative · entry 1

MORIKIS JOHN G · CIK 0001203523 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 117,340

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 29, 2020.

Read SEC document
August 07, 2020 Filed Aug 11, 2020 13:58 UTC
IPPOLITO PETER J.President, The Americas Group
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 949 $0.00 Strike: $239.55 $0.00
Disclosure

SEC source: 0001209191-20-046053 · doc4.xml · derivative · entry 7

IPPOLITO PETER J. · CIK 0001729232 · President, The Americas Group

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 417

Underlying: Common Stock · 949 shares

Expires 2025-10-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 07, 2020 Filed Aug 11, 2020 13:58 UTC
IPPOLITO PETER J.President, The Americas Group
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 1,367 $0.00 Strike: $239.55 $0.00
Disclosure

SEC source: 0001209191-20-046053 · doc4.xml · derivative · entry 6

IPPOLITO PETER J. · CIK 0001729232 · President, The Americas Group

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,367 shares

Expires 2025-10-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 07, 2020 Filed Aug 11, 2020 13:58 UTC
IPPOLITO PETER J.President, The Americas Group
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 1,367 $0.00 Strike: $239.55 $0.00
Disclosure

SEC source: 0001209191-20-046053 · doc4.xml · derivative · entry 5

IPPOLITO PETER J. · CIK 0001729232 · President, The Americas Group

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,367 shares

Expires 2025-10-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 07, 2020 Filed Aug 11, 2020 13:58 UTC
IPPOLITO PETER J.President, The Americas Group
SaleCommon Stock 3,683 $656.35 $2,417,337.05
Disclosure

SEC source: 0001209191-20-046053 · doc4.xml · nonDerivative · entry 3

IPPOLITO PETER J. · CIK 0001729232 · President, The Americas Group

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $656.30 to $656.57 inclusive. The reporting person undertakes to provide to The Sherwin-Williams Company, any security holder of The Sherwin-Williams Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.

Read SEC document
August 07, 2020 Filed Aug 11, 2020 13:58 UTC
IPPOLITO PETER J.President, The Americas Group
SaleCommon Stock 1,332 $655.62 $873,285.84
Disclosure

SEC source: 0001209191-20-046053 · doc4.xml · nonDerivative · entry 2

IPPOLITO PETER J. · CIK 0001729232 · President, The Americas Group

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,683

Read SEC document
August 07, 2020 Filed Aug 11, 2020 13:58 UTC
IPPOLITO PETER J.President, The Americas Group
Exercise / conversionCommon Stock 3,683 $239.55 $882,262.65
Disclosure

SEC source: 0001209191-20-046053 · doc4.xml · nonDerivative · entry 1

IPPOLITO PETER J. · CIK 0001729232 · President, The Americas Group

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,015

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
July 29, 2020 Filed Jul 31, 2020 17:10 UTC
GILLIGAN THOMAS PSVP-Human Resources
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 655 $0.00 Strike: $180.46 $0.00
Disclosure

SEC source: 0001209191-20-044181 · doc4.xml · derivative · entry 10

GILLIGAN THOMAS P · CIK 0001661198 · SVP-Human Resources

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 655 shares

Expires 2023-10-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
July 29, 2020 Filed Jul 31, 2020 17:10 UTC
GILLIGAN THOMAS PSVP-Human Resources
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 654 $0.00 Strike: $180.46 $0.00
Disclosure

SEC source: 0001209191-20-044181 · doc4.xml · derivative · entry 9

GILLIGAN THOMAS P · CIK 0001661198 · SVP-Human Resources

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 654 shares

Expires 2023-10-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
July 29, 2020 Filed Jul 31, 2020 17:10 UTC
GILLIGAN THOMAS PSVP-Human Resources
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 655 $0.00 Strike: $180.46 $0.00
Disclosure

SEC source: 0001209191-20-044181 · doc4.xml · derivative · entry 8

GILLIGAN THOMAS P · CIK 0001661198 · SVP-Human Resources

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 655 shares

Expires 2023-10-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
July 29, 2020 Filed Jul 31, 2020 17:10 UTC
GILLIGAN THOMAS PSVP-Human Resources
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 1,000 $0.00 Strike: $154.43 $0.00
Disclosure

SEC source: 0001209191-20-044181 · doc4.xml · derivative · entry 7

GILLIGAN THOMAS P · CIK 0001661198 · SVP-Human Resources

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,000 shares

Expires 2022-10-16

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
July 29, 2020 Filed Jul 31, 2020 17:10 UTC
GILLIGAN THOMAS PSVP-Human Resources
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 1,000 $0.00 Strike: $154.43 $0.00
Disclosure

SEC source: 0001209191-20-044181 · doc4.xml · derivative · entry 6

GILLIGAN THOMAS P · CIK 0001661198 · SVP-Human Resources

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,000 shares

Expires 2022-10-16

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
July 29, 2020 Filed Jul 31, 2020 17:10 UTC
GILLIGAN THOMAS PSVP-Human Resources
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 1,000 $0.00 Strike: $154.43 $0.00
Disclosure

SEC source: 0001209191-20-044181 · doc4.xml · derivative · entry 5

GILLIGAN THOMAS P · CIK 0001661198 · SVP-Human Resources

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,000 shares

Expires 2022-10-16

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
July 29, 2020 Filed Jul 31, 2020 17:10 UTC
GILLIGAN THOMAS PSVP-Human Resources
SaleCommon Stock 4,964 $642.70 $3,190,362.80
Disclosure

SEC source: 0001209191-20-044181 · doc4.xml · nonDerivative · entry 3

GILLIGAN THOMAS P · CIK 0001661198 · SVP-Human Resources

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,751

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $642.60 to $642.88. The reporting person undertakes to provide to The Sherwin-Williams Company, any security holder of The Sherwin-Williams Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.

Read SEC document
July 29, 2020 Filed Jul 31, 2020 17:10 UTC
GILLIGAN THOMAS PSVP-Human Resources
Exercise / conversionCommon Stock 1,964 $180.46 $354,423.44
Disclosure

SEC source: 0001209191-20-044181 · doc4.xml · nonDerivative · entry 2

GILLIGAN THOMAS P · CIK 0001661198 · SVP-Human Resources

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,715

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
July 29, 2020 Filed Jul 31, 2020 17:10 UTC
GILLIGAN THOMAS PSVP-Human Resources
Exercise / conversionCommon Stock 3,000 $154.43 $463,297.50
Disclosure

SEC source: 0001209191-20-044181 · doc4.xml · nonDerivative · entry 1

GILLIGAN THOMAS P · CIK 0001661198 · SVP-Human Resources

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,751

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
July 17, 2020 Filed Jul 21, 2020 15:48 UTC
ERTER AARON MPresident, Perf Coatings Grp
Tax withholdingCommon Stock 485 $606.04 $293,929.40
Disclosure

SEC source: 0001209191-20-043130 · doc4.xml · nonDerivative · entry 1

ERTER AARON M · CIK 0001713958 · President, Perf Coatings Grp

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,086

F1 · kind: Shares automatically and mandatorily withheld to satisfy the tax withholding requirement upon the vesting of time-based restricted stock units.

Read SEC document
July 06, 2020 Filed Jul 8, 2020 20:26 UTC GrantPhantom Stock Units · Derivative 62.9 $588.25 $37,000.93
Disclosure

SEC source: 0001209191-20-041753 · doc4.xml · derivative · entry 1

KROPF SUSAN J · CIK 0001051402 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,144.43

Underlying: Common Stock · 62.9 shares

Expires not disclosed

F1 · derivative.exercise_price: Represents the number of phantom stock units acquired by the reporting person (in an exempt transaction) under the 2005 Director Deferred Fee Plan. Each phantom stock unit is the economic equivalent of one share of common stock. The phantom stock units become payable solely in cash generally upon the reporting person's retirement.

F1 · shares: Represents the number of phantom stock units acquired by the reporting person (in an exempt transaction) under the 2005 Director Deferred Fee Plan. Each phantom stock unit is the economic equivalent of one share of common stock. The phantom stock units become payable solely in cash generally upon the reporting person's retirement.

F1 · derivative.exercise_date: Represents the number of phantom stock units acquired by the reporting person (in an exempt transaction) under the 2005 Director Deferred Fee Plan. Each phantom stock unit is the economic equivalent of one share of common stock. The phantom stock units become payable solely in cash generally upon the reporting person's retirement.

F1 · derivative.expiration_date: Represents the number of phantom stock units acquired by the reporting person (in an exempt transaction) under the 2005 Director Deferred Fee Plan. Each phantom stock unit is the economic equivalent of one share of common stock. The phantom stock units become payable solely in cash generally upon the reporting person's retirement.

F2 · balance_after: Includes phantom stock units acquired pursuant to the dividend reinvestment feature of the plan.

Read SEC document
July 06, 2020 Filed Jul 8, 2020 20:23 UTC GrantCommon Stock 68 $588.25 $40,001.00
Disclosure

SEC source: 0001209191-20-041752 · doc4.xml · nonDerivative · entry 1

WUNNING STEVEN H · CIK 0001171788 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Deferred Plan

Disclosed balance after: 1,976.15

F1 · kind: Represents the number of phantom stock units acquired by the reporting person (in an exempt transaction) under the 2005 Director Deferred Fee Plan. Each phantom stock unit is the economic equivalent of one share of common stock. The phantom stock units become payable solely in stock generally upon the reporting person's retirement.

F2 · balance_after: Phantom stock units listed are held pursuant to the 2005 Director Deferred Fee Plan, which includes phantom stock units acquired pursuant to the dividend reinvestment feature of such plan.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.